$1.9 Billion is the total value of Rubric Capital Management LP's 88 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WSC | New | WILLSCOT MOBIL MINI HLDNG CO | $42,818,000 | – | 1,320,713 | +100.0% | 2.25% | – |
| IGT | New | INTERNATIONAL GAME TECHNOLOG | $23,890,000 | – | 1,287,163 | +100.0% | 1.26% | – |
| NGM | New | NGM BIOPHARMACEUTICALS INC | $10,225,000 | – | 797,588 | +100.0% | 0.54% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $9,236,000 | – | 1,231,483 | +100.0% | 0.48% | – |
| EPZM | New | EPIZYME INC | $9,237,000 | – | 6,283,690 | +100.0% | 0.48% | – |
| New | THERAPEUTICSMD INC | $7,879,000 | – | 791,831 | +100.0% | 0.41% | – | |
| RGNX | New | REGENXBIO INC | $7,100,000 | – | 287,467 | +100.0% | 0.37% | – |
| OVID | New | OVID THERAPEUTICS INC | $6,198,000 | – | 2,882,706 | +100.0% | 0.33% | – |
| KRYS | New | KRYSTAL BIOTECH INC | $6,081,000 | – | 92,609 | +100.0% | 0.32% | – |
| AVEO | New | AVEO PHARMACEUTICALS INC | $6,061,000 | – | 923,885 | +100.0% | 0.32% | – |
| New | ADAGIO THERAPEUTICS INC | $5,944,000 | – | 1,812,347 | +100.0% | 0.31% | – | |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $5,073,000 | – | 523,528 | +100.0% | 0.27% | – |
| TRVI | New | TREVI THERAPEUTICS INC | $4,997,000 | – | 1,778,420 | +100.0% | 0.26% | – |
| ARQT | New | ARCUTIS BIOTHERAPEUTICS INC | $4,823,000 | – | 226,346 | +100.0% | 0.25% | – |
| ATAI | New | ATAI LIFE SCIENCES NV | $4,802,000 | – | 1,319,137 | +100.0% | 0.25% | – |
| STRO | New | SUTRO BIOPHARMA INC | $4,689,000 | – | 900,000 | +100.0% | 0.25% | – |
| DTIL | New | PRECISION BIOSCIENCES INC | $4,251,000 | – | 2,657,115 | +100.0% | 0.22% | – |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $4,183,000 | – | 986,453 | +100.0% | 0.22% | – |
| CGEM | New | CULLINAN ONCOLOGY INC | $3,812,000 | – | 297,347 | +100.0% | 0.20% | – |
| New | 2SEVENTY BIO INC | $3,498,000 | – | 265,000 | +100.0% | 0.18% | – | |
| XOMA | New | XOMA CORP DEL | $3,330,000 | – | 149,446 | +100.0% | 0.18% | – |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $3,070,000 | – | 283,694 | +100.0% | 0.16% | – |
| TARS | New | TARSUS PHARMACEUTICALS INC | $2,959,000 | – | 202,648 | +100.0% | 0.16% | – |
| CARA | New | CARA THERAPEUTICS INC | $2,437,000 | – | 266,966 | +100.0% | 0.13% | – |
| ANIP | New | ANI PHARMACEUTICALS INC | $2,446,000 | – | 82,444 | +100.0% | 0.13% | – |
| PASG | New | PASSAGE BIO INC | $1,940,000 | – | 822,105 | +100.0% | 0.10% | – |
| SELB | New | SELECTA BIOSCIENCES INC | $945,000 | – | 721,245 | +100.0% | 0.05% | – |
| HOWL | New | WEREWOLF THERAPEUTICS INC | $838,000 | – | 204,996 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAGNACHIP SEMICONDUCTOR CORP | 28 | Q3 2023 | 4.7% |
| BGC PARTNERS INC | 20 | Q2 2023 | 4.6% |
| MR COOPER GROUP INC | 20 | Q3 2023 | 5.9% |
| PAR PACIFIC HOLDINGS INC | 18 | Q3 2023 | 3.9% |
| RADIUS HEALTH INC | 16 | Q2 2022 | 4.3% |
| CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 2.6% |
| HERON THERAPEUTICS INC | 15 | Q3 2023 | 9.0% |
| COLLEGIUM PHARMACEUTICAL INC | 15 | Q3 2023 | 3.9% |
| AAR CORP | 14 | Q3 2023 | 3.2% |
| GREEN PLAINS INC | 14 | Q3 2022 | 4.1% |
View Rubric Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ | July 25, 2023 | 26,713,503 | 19.0% |
| Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
| BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
| EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
| Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
| Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
| Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
| Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
| Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
| ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
View Rubric Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| DFAN14A | 2024-05-03 |
| DFAN14A | 2024-05-01 |
| DFAN14A | 2024-04-30 |
| DFAN14A | 2024-04-29 |
| DEFC14A | 2024-04-17 |
| DFAN14A | 2024-04-17 |
| SC 13D/A | 2024-04-16 |
| PRRN14A | 2024-04-02 |
| PRRN14A | 2024-03-26 |
| DFAN14A | 2024-03-11 |
View Rubric Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.